Sex Cord Gonadal Stromal Tumor Companies

Latest Sex Cord-Gonadal Stromal Tumor Companies Updates:

OncoCell MDx launches OncoCell GIST test, a molecular diagnostic test for the detection of genetic mutations associated with SCGSTs: This test helps differentiate SCGSTs from other tumor types and guide treatment decisions

Bio-Rad Laboratories announces launch of QX200 Droplet Digital PCR (ddPCR) System, offering a more accurate and sensitive way to detect genetic mutations in SCGSTs: This technology potentially allows for better risk stratification and personalized treatment planning.

Foundation Medicine expands FoundationOne CDx panel to include genes associated with SCGSTs: This comprehensive genetic testing platform assists in identifying specific mutations and tailoring treatment accordingly.

Exact Sciences collaborates with academic institutions to develop liquid biopsy tests for SCGSTs: Early detection through blood-based testing could revolutionize diagnosis and management of these tumors.

List of Sex Cord-Gonadal Stromal Tumor Key companies in the market:

• Abbott


• Abcam plc


• Affymetrix, Inc.


• Agilent Technologies, Inc.


• Beckman, Dickinson and Company (BD)


• Bio SB Inc.


• BioCurex, BioModa, Inc.,


• Bio-Rad Laboratories, Inc.


• Boston Scientific Corporation


• Cell Signaling Technology, Inc.


• Clarient, Inc.